Schroeder Institute for Tobacco Research and Policy Studies, Legacy, 1724 Massachusetts Avenue NW, Washington, DC 20036, USA.
Curr HIV/AIDS Rep. 2012 Dec;9(4):375-84. doi: 10.1007/s11904-012-0138-4.
Tobacco use, especially cigarette smoking, is higher than average in persons living with HIV/AIDS (PLWHA). The Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence states that, during every medical encounter, all smokers should be offered smoking cessation counseling, along with approved medications. The Guideline also recognizes PLWHA as a priority population, given the scarcity of research on effective cessation treatments in this group. The scant evidence suggests that conventional treatments, though worthwhile, are not as successful as might be hoped for. The reasons for this are not entirely clear, but may have to do with the complex array of medical and psychosocial factors that complicate their lives. Clinicians should consider re-treatment strategies for those patients who encounter difficulty when quitting smoking with conventional approaches, switching or augmenting treatments as needed to minimize adverse experiences, and to maximize tolerability, adherence, and cessation outcomes.
吸烟,尤其是吸食香烟,在艾滋病毒/艾滋病感染者(PLWHA)中比一般人群更为常见。《公共卫生服务治疗烟草使用和依赖临床实践指南》指出,在每次医疗接触中,所有吸烟者都应提供戒烟咨询,并使用经批准的药物。鉴于针对该人群的有效戒烟治疗研究匮乏,该指南还将 PLWHA 视为重点人群。为数不多的证据表明,尽管常规治疗有一定价值,但并不像人们所希望的那样成功。其原因尚不完全清楚,但可能与使他们的生活变得复杂的一系列复杂的医学和社会心理因素有关。对于那些在采用常规方法戒烟时遇到困难的患者,临床医生应考虑重新治疗策略,根据需要切换或增强治疗,以尽量减少不良体验,并最大限度地提高耐受性、依从性和戒烟效果。